Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists demonstrate consistent risk reductions for mortality, myocardial infarction, stroke, heart failure, and renal outcomes, irrespective of their effects on glycemia
GLP-1-based therapies are legitimate prescription medications for approved medical conditions, and their use is protected health information under HIPAA regulations in the United States
It also aids in chronic weight management , ensuring that you maintain a healthy weight in the long run
Am Heart J 2006;151:91.ArticlePubMed 35
#MyFitnessPal #GLP1 #DigitalHealth #HealthTech #WeightManagement GLP-1 Medication Users See 40% Greater Weight Loss with MyFitnessPal A 10-month observational study (n=372) of patients on GLP-1 medications found that those pairing their treatment with MyFitnessPal reported 40% greater average weight loss compared to those not using the platform (11.6% vs
Refresh your body with our customized hydration and vitamin infusions
